Search
Aug 28, 2023
BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress
Seth Ettenberg describes safety, imaging, and efficacy takeaways from the 12-patient study.
Jun 28, 2023
Using a cell therapy as a potential treatment for Parkinson’s with BlueRock's CEO
CEO Seth Ettenberg explains how BlueRock is using pluripotent stems cells to try to restore dopamine production in Parkinson’s patients.